Literature DB >> 23045719

Tracking of mouse breast cancer stem-like cells with Salmonella.

Wen-Wei Chang1, Yu-Diao Kuan, Man-Chin Chen, Song-Tao Lin, Che-Hsin Lee.   

Abstract

Systemic administration of Salmonella to tumor-bearing mice leads to the preferential accumulation within tumor sites and retardation of tumor growth. The cancer stem-like cell (CSC) hypothesis suggests that CSCs are the root of cancer and induce metastasis and recurrence. The objective of this study was to examine if Salmonella could inhibit the growth of CSCs derived from mouse breast cancer. Systemically injected Salmonella preferentially accumulated within tumors for at least three weeks and the bacteria accumulated preferentially not only in subcutaneous but also in orthotopic tumors over livers and spleens at ratios ranging from 1000:1 to 10,000:1. Salmonella were capable of delaying tumor growth and enhancing survival in both subcutaneous and orthotopic tumor models. More strikingly, Salmonella acted to retard tumor growth and extensively prolong the survival time of the mice bearing CSC-induced tumors. Our results also found that Salmonella predominantly, although not exclusively, resided in the CSC regions of the tumor. These data suggest that Salmonella can inhibit the growth of breast cancer by targeting the CSC niche. In conclusion, Salmonella can be used for the management of breast cancer.

Entities:  

Mesh:

Year:  2012        PMID: 23045719     DOI: 10.1258/ebm.2012.012063

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  12 in total

1.  Connexin 43 suppresses tumor angiogenesis by down-regulation of vascular endothelial growth factor via hypoxic-induced factor-1α.

Authors:  Wei-Kuang Wang; Man-Chin Chen; Hon-Fai Leong; Yu-Liang Kuo; Chun-Yu Kuo; Che-Hsin Lee
Journal:  Int J Mol Sci       Date:  2014-12-26       Impact factor: 5.923

2.  Salmonella overcomes tumor immune tolerance by inhibition of tumor indoleamine 2, 3-dioxygenase 1 expression.

Authors:  Yu-Diao Kuan; Che-Hsin Lee
Journal:  Oncotarget       Date:  2016-01-05

3.  Salmonella VNP20009-mediated RNA interference of ABCB5 moderated chemoresistance of melanoma stem cell and suppressed tumor growth more potently.

Authors:  Xiaoxin Zhang; Xiawei Cheng; Yueyang Lai; Yuqiang Zhou; Wenmin Cao; Zi-Chun Hua
Journal:  Oncotarget       Date:  2016-03-22

4.  Salmonella inhibits tumor angiogenesis by downregulation of vascular endothelial growth factor.

Authors:  Dom-Gene Tu; Wen-Wei Chang; Song-Tao Lin; Chun-Yu Kuo; Yu-Tzu Tsao; Che-Hsin Lee
Journal:  Oncotarget       Date:  2016-06-21

5.  Salmonella mediated the hemagglutinating virus of Japan-envelope transfer suppresses tumor growth.

Authors:  Che-Hsin Lee; Tomoyuki Nishikawa; Yasufumi Kaneda
Journal:  Oncotarget       Date:  2017-05-23

6.  Downregulations of AKT/mTOR Signaling Pathway for Salmonella-Mediated Suppression of Matrix Metalloproteinases-9 Expression in Mouse Tumor Models.

Authors:  Yu-Tzu Tsao; Chun-Yu Kuo; Shun-Ping Cheng; Che-Hsin Lee
Journal:  Int J Mol Sci       Date:  2018-05-31       Impact factor: 5.923

Review 7.  Tumorsphere as an effective in vitro platform for screening anti-cancer stem cell drugs.

Authors:  Che-Hsin Lee; Cheng-Chia Yu; Bing-Yen Wang; Wen-Wei Chang
Journal:  Oncotarget       Date:  2016-01-12

8.  Salmonella Bacterial Monotherapy Reduces Autochthonous Prostate Tumor Burden in the TRAMP Mouse Model.

Authors:  Robert A Kazmierczak; Bettina Gentry; Tyler Mumm; Heide Schatten; Abraham Eisenstark
Journal:  PLoS One       Date:  2016-08-09       Impact factor: 3.240

9.  Salmonella Overcomes Drug Resistance in Tumor through P-glycoprotein Downregulation.

Authors:  Chih-Jen Yang; Wen-Wei Chang; Song-Tao Lin; Man-Chin Chen; Che-Hsin Lee
Journal:  Int J Med Sci       Date:  2018-03-09       Impact factor: 3.738

10.  Near-Infrared-Triggered Photodynamic Therapy toward Breast Cancer Cells Using Dendrimer-Functionalized Upconversion Nanoparticles.

Authors:  Bing-Yen Wang; Ming-Liang Liao; Guan-Ci Hong; Wen-Wei Chang; Chih-Chien Chu
Journal:  Nanomaterials (Basel)       Date:  2017-09-11       Impact factor: 5.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.